HORIZON program provides treatment recommendations for patients with moderate to severe psoriasis (Part 1)

HORIZON program provides recommendations for psoriasis patients with specific joint involvement. Dr. Ron Vender, Regional Chair of the HORIZON Program, speaks about secukinumab in use for scalp psoriasis, nail psoriasis and palmoplantar psoriasis.